Abstract

6P - The antitumor activity of lenvatinib (LEN) in combination with everolimus (EVE) in human renal cell carcinoma (RCC) xenograft models is dependent on VEGFR and FGFR signaling

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract 12: Antitumor activity of lenvatinib in combination with everolimus or an anti-PD1 antibody in preclinical RCC models
Yusuke Adachi ... Masahiro Matsuki
American Journal of Cancer | VOL. 78
Yusuke Adachi, et. al.Yusuke Adachi ... Masahiro Matsuki
01 Jul 2018
Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.
T Y Jeon ... C K Kim
The British journal of radiology | VOL. 88
T Y Jeon, et. al.T Y Jeon ... C K Kim
02 Jul 2015
Tumor localization and therapeutic potential of an antitumor-anti-CD3 heteroconjugate antibody in human renal cell carcinoma xenograft models
Zhenping Zhu ... David J Mckean
Cancer Letters | VOL. 86
Zhenping Zhu, et. al.Zhenping Zhu ... David J Mckean
01 Oct 1994
Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma
Benjamin Namdarian ... Kevin V.S Tan
British Journal of Urology | VOL. 106
Benjamin Namdarian, et. al.Benjamin Namdarian ... Kevin V.S Tan
14 Sep 2010
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first-line and at relapse of chronic lymphocytic leukaemia
B Eichhorst ... C Buske
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
B Eichhorst, et. al.B Eichhorst ... C Buske
01 Jul 2024
Proofreading the way: immune checkpoint inhibitors in polymerase ε/polymerase δ (POLE/POLD1)-altered colorectal cancer
M Cecchini ... R Sundar
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
M Cecchini, et. al.M Cecchini ... R Sundar
01 Jul 2024
Table of Contents
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
View more papers